Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 12,270 | 11,078 | 13,287 | 15,345 | 11,122 |
| Cost of Goods | 4,214 | 3,366 | 4,400 | 4,466 | 2,757 |
| Gross Profit | 8,056 | 7,712 | 8,887 | 10,879 | 8,365 |
| Operating Expenses | 18,008 | 19,747 | 17,255 | 17,862 | 17,647 |
| Operating Income | -9,738 | -11,669 | -7,968 | -6,517 | -8,525 |
| Interest Expense | 3,479 | 3,589 | 6,554 | 6,223 | 6,095 |
| Other Income | -3 | -13,687 | -33 | 373 | -52 |
| Pre-tax Income | -13,220 | -28,945 | -14,555 | -12,367 | -14,672 |
| Net Income Continuous | -13,220 | -28,945 | -14,555 | -12,367 | -14,672 |
| Net Income | $-13,220 | $-28,945 | $-14,555 | $-12,367 | $-14,672 |
| EPS Basic Total Ops | -0.32 | -0.74 | -0.37 | -0.33 | -0.41 |
| EPS Basic Continuous Ops | -0.32 | -0.74 | -0.37 | -0.33 | -0.41 |
| EPS Diluted Total Ops | -0.32 | -0.74 | -0.37 | -0.33 | -0.41 |
| EPS Diluted Continuous Ops | -0.32 | -0.74 | -0.37 | -0.33 | -0.41 |
| EBITDA(a) | $-8,971 | $-10,811 | $-6,016 | $-4,571 | $-6,586 |